|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
Walgreen Company 8-K 2010 SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): February 17, 2010
![]() WALGREEN
CO.
(Exact
name of registrant as specified in its charter)
Registrant’s
telephone number, including area code:(847) 940-2500
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
On
February 17, 2010, Walgreen Co. (the “Company”) issued a press release
announcing the execution of a purchase agreement among the Company, Duane Reade
Holdings, Inc. (“Duane Reade”), and Duane Reade Shareholders, LLC, pursuant to
which the Company has agreed to acquire Duane Reade. A copy of this press
release is attached hereto as Exhibit 99.1.
In
addition to issuing the press release, Walgreen Co. also conducted a conference
call and webcast regarding the acquisition. Slides prepared for the purposes of
the conference call are available on the Walgreens investor relations Web site
at http://investor.walgreens.com.
Item
9.01 Financial
Statements and Exhibits.
The
following exhibit is being filed as part of this Form 8-K:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
EXHIBIT
INDEX
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||